Evidence map›Paper›PMID 32989522›Full record

ArticleWorld journal of microbiology & biotechnology2020

Structural and functional comparison of Saccharomonospora azurea strains in terms of primycin producing ability.

Márk Kovács, Dénes Seffer, Ágota Pénzes-Hűvös, Ákos Juhász, Ildikó Kerepesi, Kitti Csepregi, Andrea Kovács-Valasek, Csaba Fekete

Abstract read
In one paragraph

Article in World journal of microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Heliyon · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Márk KovácsPannonPharma Pharmaceutical Ltd., 7720, Pécsvárad, Hungary.
Dénes SefferPannonPharma Pharmaceutical Ltd., 7720, Pécsvárad, Hungary.
Ágota Pénzes-HűvösPannonPharma Pharmaceutical Ltd., 7720, Pécsvárad, Hungary.
Ákos JuhászFaculty of Agricultural and Environmental Sciences, Institute of Biological Sciences, Szent István University, 2100, Gödöllő, Hungary.
Ildikó KerepesiFaculty of Sciences, Institute of Biology, University of Pécs, 7624, Pécs, Hungary.
Kitti CsepregiFaculty of Sciences, Institute of Biology, University of Pécs, 7624, Pécs, Hungary.
Andrea Kovács-ValasekFaculty of Sciences, Institute of Biology, University of Pécs, 7624, Pécs, Hungary.
Csaba FeketeFaculty of Sciences, Institute of Biology, University of Pécs, 7624, Pécs, Hungary. fekete@gamma.ttk.pte.hu.ORCID http://orcid.org/0000-0002-6562-6106

Funding

Government of Hungary GINOP-2.1.2-8.1.4-16Government of Hungary GINOP-2.3.2.-15-2016-00047
6 · The paper itself

Abstract

Emerging and re-emerging microbial pathogens, together with their rapid evolution and adaptation against antibiotics, highlight the importance not only of screening for new antimicrobial agents, but also for deepening knowledge about existing antibiotics. Primycin is a large 36-membered non-polyene macrolide lactone exclusively produced by Saccharomonospora azurea. This study provides information about strain dependent primycin production ability in conjunction with the structural, functional and comparative genomic examinations. Comparison of high- and low-primycin producer strains, transcriptomic analysis identified a total of 686 differentially expressed genes (DEGs), classified into diverse Cluster of Orthologous Groups. Among them, genes related to fatty acid synthesis, self-resistance, regulation of secondary metabolism and agmatinase encoding gene responsible for catalyze conversion between guanidino/amino forms of primycin were discussed. Based on in silico data mining methods, we were able to identify DEGs whose altered expression provide a good starting point for the optimization of fermentation processes, in order to perform targeted strain improvement and rational drug design.

Indexed as

ActinobacteriaAnti-Bacterial AgentsCulture MediaGene Expression ProfilingGene Expression Regulation, BacterialGenomicsMacrolidesMultigene FamilyRNA, BacterialAnti-Bacterial AgentsCulture MediaMacrolidesprimycinRNA, BacterialPolyketide biosynthetic genesPrimycinSaccharomonospora azureaStructural and functional genomics

Identifiers

PMID32989522
PMCPMC7522111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.